Abstract
Purpose
This study evaluated the response to electrical cardioversion (EC) and the effect on the myocardial performance index (MPI) in patients with persistent and long-standing persistent atrial fibrillation (AF).
Methods
We enrolled 103 patients (mean age 69.6 ± 8.9 years, 40.7 % males) with a diagnosis of persistent and long-standing persistent AF. EC was applied to all patients after one g of amiodarone administration. Echocardiographic findings before EC were compared in patients with successful versus unsuccessful cardioversions and in patients with maintained sinus rhythm (SR) versus those with AF recurrence at the end of the first month. We also compared echocardiographic data before EC versus at the end of the first month in the same patients with maintained SR.
Results
SR was achieved in 72.8 % of patients and was continued at the end of the first month in 69.3 % of the patients. The MPI value of all patients was found to be 0.73 ± 0.21. The size of the left atrium was determined to be an independent predictor of the maintenance of SR at 1 month. In subgroup analyses, when we compared echocardiographic findings before EC and at the end of the first month in patients with maintained SR, the MPI (0.66 ± 0.14 vs 0.56 ± 0.09, p < 0.001) values were significantly decreased.
Conclusions
Our study is the first to show impairment of the MPI, which is an indicator of systolic and diastolic function, in patients with persistent and long-standing persistent AF and improvement of the MPI after successful EC.
Similar content being viewed by others
References
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., et al. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine, 347, 1825–1833.
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., et al. (2002). A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New England Journal of Medicine, 347, 1834–1840.
Carlsson, J., Miketic, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., et al. (2003). Randomized trial of rate-control versus rhythmcontrol in persistent atrial fibrillation. Journal of the American College of Cardiology, 4, 1690–1696.
Opolski, G., Torbicki, A., Kosior, D. A., Szulc, M., Wozakowska-Kaplon, B., Kolodziej, P., et al. (2004). Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest, 126, 476–486.
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., et al. (2008). Rhythm control versus rate control for atrial fibrillation and heart failure. New England Journal of Medicine, 358(25), 2667–2677.
Ogawa, S., Yamashita, T., Yamazaki, T., Aizawa, Y., Atarashi, H., Inoue, H., et al. (2009). Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circulation Journal, 73(2), 242–248.
Hohnloser, S. H., Kuck, K. H., & Lilienthal, J. (2000). Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet, 356(9244), 1789–1794.
Wozakowska-Kapłon, B., & Opolski, G. (2004). Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. International Journal of Cardiology, 96(2), 171–176.
Bernard-Brunet, A., Saint Etienne, C., Piver, E., Zannad, N., Pages, J. C., Fauchier, L., et al. (2014). Incomplete recovery of mechanical and endocrine left atrial functions one month after electrical cardioversion for persistent atrial fibrillation: a pilot study. Journal of Translational Medicine, 12, 51.
Spring, A., Kosmala, W., & Mysiak, A. (1997). The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation. Przegla̧d Lekarski, 54(9), 585–590.
Wozakowska-Kapłon, B., & Opolski, G. (2003). Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. Journal of the American College of Cardiology, 41(10), 1716–1720.
Wozakowska-Kapłon, B., & Opolski, G. (2003). Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure. Kardiologia Polska, 59(9), 213–223.
Camm, A. J., Lip, G. Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Europace, 14, 1385–1413.
Tei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., et al. (1995). New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. Journal of Cardiology, 26(6), 357–366.
Tei, C., Nishimura, R. A., Seward, J. B., & Tajik, A. J. (1997). Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. Journal of the American Society of Echocardiography, 10, 169–178.
Bruch, C., Schmermund, A., Dagres, N., Katz, M., Bartel, T., & Erbel, R. (2002). Tei index in coronary artery disease validation in patients with overall cardiac and isolated diastolic dysfunction. Zeitschrift für Kardiologie, 91(6), 472–480.
Salehian, O., Schwerzmann, M., Merchant, N., Webb, G. D., Siu, S. C., & Therrien, J. (2004). Assessment of systemic right ventricular function in patients with transposition of the great arteries using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation, 110, 3229–3233.
Vivekananthan, K., Kalapura, T., Mehra, M., Lavie, C., Milani, R., Scott, R., et al. (2002). Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. American Journal of Cardiology, 90(5), 517–520.
Haque, A., Otsuji, Y., Yoshifuku, S., Kumanohoso, T., Zhang, H., Kisanuki, A., et al. (2002). Effects of valve dysfunction on Doppler Tei index. Journal of the American Society of Echocardiography, 15(9), 877–883.
Ikeda, R., Yuda, S., Kobayashi, N., Nakahara, N., Nakata, T., Tsuchihashi, K., et al. (2001). Usefulness of right ventricular Doppler index for predicting outcome in patients with dilated cardiomyopathy. Journal of Cardiology, 37(3), 157–164.
Tei, C., Dujardin, K. S., Hodge, D. O., Kyle, R. A., Tajik, A. J., & Seward, J. B. (1996). Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. Journal of the American College of Cardiology, 28(3), 658–664.
Grapsa, I., Pavlopoulos, H., Dawson, D., Gibbs, J. S., & Nihoyannopoulos, P. (2007). Retrospective study of pulmonary hypertensive patients: is right ventricular myocardial performance index a vital prognostic factor? Hellenic Journal of Cardiology, 48, 152–160.
Møller, J. E., Dahlström, U., Gøtzsche, O., Lahiri, A., Skagen, K., Andersen, G. S., et al. (2004). Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy. American Heart Journal, 147, 494–501.
Chu, C. Y., Lee, W. H., Hsu, P. C., Lee, H. H., Chiu, C. A., Su, H. M., et al. (2014). Myocardial performance index derived from pre-ejection period as a novel and useful predictor of cardiovascular events in atrial fibrillation. Journal of Cardiology. doi:10.1016/j.jjcc.2014.07.014.
Su, H. M., Lin, T. H., Hsu, P. C., Chu, C. Y., Lee, W. H., Lee, C. S., et al. (2011). Myocardial performance index derived from preejection period: novel and feasible parameter in evaluation of cardiac performance in patients with permanent atrial fibrillation. Echocardiography, 28(10), 1081–1087.
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., et al. (2005). Recommendations for chamber quantification: a report from the American Society of Echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography, 18(12), 1440–1463.
Resnekov, L., & McDonald, L. (1968). Appraisal of electroconversion in treatment of cardiac dysrhythmias. British Heart Journal, 30, 786–811.
Van Gelder, I. C., Crijns, H. J., Van Gilst, W. H., Verwer, R., & Lie, K. I. (1991). Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. American Journal of Cardiology, 68(1), 41–46.
Naccarelli, G. V., Dell’Orfano, J. T., Wolbrette, D. L., Patel, H. M., & Luck, J. C. (2000). Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. American Journal of Cardiology, 85(10A), 36–45.
Dittrich, H. C., Erickson, J. S., Schneiderman, T., Blacky, A. R., Savides, T., & Nicod, P. H. (1989). Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. American Journal of Cardiology, 63(3), 193–197.
Dalzell, G. W., Anderson, J., & Adgey, A. A. (1990). Factors determining success and energy requirements for cardioversion of atrial fibrillation. Quarterly Journal of Medicine, 76(281), 903–913.
Raitt, M. H., Volgman, A. S., Zoble, R. G., Charbonneau, L., Padder, F. A., O'Hara, G. E., et al. (2006). Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. American Heart Journal, 151, 390–396.
Olshansky, B., Heller, E. N., Mitchell, L. B., Chandler, M., Slater, W., Green, M., et al. (2005). Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow- Up Investigation of Rhythm Management (AFFIRM) study. Journal of the American College of Cardiology, 45(12), 2026–2033.
Bertaglia, E., D’Este, D., Zerbo, F., Zoppo, F., Delise, P., & Pascotto, P. (2002). Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm; a randomized study. European Heart Journal, 23(19), 1522–1528.
Van Gelder, I. C., Crijns, H. J., Tieleman, R. G., Brügemann, J., De Kam, P. J., Gosselink, A. T., et al. (1996). Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Archives of Internal Medicine, 156(22), 2585–2592.
Moller, J. E., Sondergaard, E., Poulsen, S. H., Appleton, C. P., & Egstrup, K. (2001). Serial Doppler echocardiographic assessment of left and right ventricular performance after a first myocardial infarction. Journal of the American Society of Echocardiography, 14(4), 249–255.
Akintunde, A. A. (2012). The clinical value of the Tei index among Nigerians with hypertensive heart failure: correlation with other conventional indices. Cardiovascular Journal of Africa, 23(1), 40–43.
Spencer, K. T., Kirkpatrick, J. N., Mor-Avi, V., Decara, J. M., & Lang, R. M. (2004). Age dependency of the Tei index of myocardial performance. Journal of the American Society of Echocardiography, 17(4), 350–352.
Tieleman, R. G., Van Gelder, I. C., Crijns, H. J., De Kam, P. J., van Den Berg, M. P., Haaksma, J., et al. (1998). Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? Journal of the American College of Cardiology, 31(1), 167–173.
Schneider, M. P., Hua, T. A., Bohm, M., Wachtell, K., Kjeldsen, S. E., & Schmieder, R. E. (2010). Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis. Journal of the American College of Cardiology, 55(21), 2299–2307.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Besli, F., Basar, C., Kecebas, M. et al. Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion. J Interv Card Electrophysiol 42, 107–115 (2015). https://doi.org/10.1007/s10840-014-9965-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-014-9965-0